Literature DB >> 9589672

A recurrent missense mutation in the KAL gene in patients with X-linked Kallmann's syndrome.

G Maya-Nuñez1, J C Zenteno, A Ulloa-Aguirre, S Kofman-Alfaro, J P Mendez.   

Abstract

Kallmann's syndrome (KS) is defined by the association of hypogonadotropic hypogonadism and anosmia or hyposmia. Segregation analysis in familial cases has demonstrated diverse inheritance patterns, suggesting the existence of several genes regulating GnRH secretion. Genetic defects have been demonstrated in the KAL gene, located on the Xp22.3 region, explaining the X-linked form of the disease. We report molecular findings regarding the KAL gene in 12 unrelated males with X-linked KS. PCR of the 14 exons of the KAL gene was performed on genomic DNA. PCR products of all exons were purified and sequenced. Genetic defects in the KAL gene were found in 7 patients. One exhibits a deletion from exon 3 to exon 5. Six individuals present a previously unidentified missense mutation in exon 11, consisting of a G to A substitution at codon 514 (GAA to AAA). In the remaining 5 individuals, no mutations were observed. We also found three different polymorphic changes. The first one, in exon 2, had not been reported previously. The other two were located at exons 11 and 12. The deletion described, comprises only part (exon 5) of the coding region of the first fibronectin type III-like repeat of the KAL protein. The rest of the deletion comprises part of the conserved cysteine-rich N-terminal region that corresponds to the whey acidic protein motif. The same missense mutation was found in 6 of the 12 patients, indicating the possibility that it derived from a common ancestor or suggesting the presence of a hot spot in this region of the gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9589672     DOI: 10.1210/jcem.83.5.4817

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Polymorphic changes in the KAL1 gene: not all of them should be classified as polymorphisms.

Authors:  D Söderlund; F Vilchis; J P Méndez
Journal:  J Endocrinol Invest       Date:  2004-09       Impact factor: 4.256

2.  Molecular modelling and experimental studies of mutation and cell-adhesion sites in the fibronectin type III and whey acidic protein domains of human anosmin-1.

Authors:  A Robertson; G S MacColl; J A Nash; M K Boehm; S J Perkins; P M Bouloux
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

Review 3.  Kallmann syndrome: fibroblast growth factor signaling insufficiency?

Authors:  Catherine Dodé; Jean-Pierre Hardelin
Journal:  J Mol Med (Berl)       Date:  2004-09-08       Impact factor: 4.599

Review 4.  The epidemiology and etiology of azoospermia.

Authors:  Marcello Cocuzza; Conrado Alvarenga; Rodrigo Pagani
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

5.  Eight rare urinary disorders in a patient with Kallmann syndrome: A case report.

Authors:  Huining Tian; Zi Yan; You Lv; Lin Sun; Xiaokun Gang; Guixia Wang
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.